Mach7 Technologies (M7T) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
29 May, 2026Executive summary
Undertook a comprehensive organizational and commercial reset, including leadership changes, cost discipline, and a sharpened product and go-to-market strategy, with a focus on sustainable, disciplined sales growth and aligning the commercial engine with strategic objectives.
Launched the modular Flamingo architecture, securing the first customer in December 2025 and targeting customer-specific imaging needs to enable new revenue streams.
Enhanced sales and marketing with new leadership, clear ownership, and improved customer engagement, resulting in higher KLAS scores and the initiation of the Flight Crew customer engagement model.
Achieved CE mark for eUnity under EU Medical Device Regulation, expanding access to Europe and the Middle East.
Achieved operational efficiencies through headcount rationalisation, infrastructure optimisation, and vendor contract renegotiation, reducing operating expenses.
Financial highlights
Revenue for H1 FY26 was AUD 13.7 million, down 23% year-over-year due to lower capital license sales, customer churn, and reduced professional services revenue.
Recurring revenue was AUD 11.6 million (85% of total), down 8% year-over-year, and covered 78% of operating expenditure.
Gross margin remained strong at 92% (down from 94% year-over-year), reflecting platform scalability.
Operating expenses decreased by 6% as cost initiatives took effect, with operating expenses at AUD 14.8 million.
Adjusted EBITDA was -AUD 2.3 million, down from AUD 0.8 million in the prior period; NPAT was -AUD 5.7 million.
Ended the half with AUD 18.5 million in cash and zero debt.
Outlook and guidance
Expecting flat revenue for FY26, with growth anticipated in FY27 as commercial momentum builds and Flamingo drives ARR growth progressively over the next two years.
Continued disciplined investment in sales, partnerships, product development, and platform scalability, with selective investment in growth-critical capabilities.
Enhanced marketing and sales initiatives, including a refreshed brand and digital presence, are underway.
Latest events from Mach7 Technologies
- Record recurring revenue and sales orders drive positive cash flow and strong FY25 outlook.M7T
H2 202429 May 2026 - Revenue up 33%, recurring revenue covers 80% of OpEx, positive EBITDA, and share buy-back announced.M7T
H1 202529 May 2026 - 16% revenue growth, recurring revenue covers 80% of OPEX, and cash flow is positive.M7T
H2 202529 May 2026 - Q3 FY26 saw positive cash flow, ARR growth, and a strong cash position amid cost discipline.M7T
Q3 202624 Apr 2026 - Stable ARR, positive cash flow, and new product traction support a confident outlook.M7T
Q2 20263 Feb 2026 - Sales orders up 52%, recurring revenue and cash at record highs, subscription growth strong.M7T
Q4 2024 TU2 Feb 2026 - CARR and ARR rose in Q1 FY25, with strong cash reserves and reaffirmed growth guidance.M7T
Q1 2025 TU17 Jan 2026 - Record sales and recurring revenue growth support a scalable, innovation-driven outlook for FY25.M7T
AGM 202412 Jan 2026 - Recurring revenue up 15.6%, strong cash, and FY25 growth guidance reaffirmed.M7T
Q2 2025 TU9 Jan 2026